실시간
BioPharma DiveCeliac disease is entering a new era of therapeutic innovationBioPharma DivePlanning a successful pivot from lab to clinicEndpoints NewsHMNC Brain Health raises $50M Series B to advance two depression drugseLifeExposure to false cardiac feedback alters pain perception and anticipatory cardiac frequencyeLifeNuclear CK1δ as a critical determinant of PER:CRY complex dynamics and circadian periodJIANGSU KANGJIAN MEDICAL APPARATUS CO.,LTD.World Cryo-Preservation Vial System - Market Analysis, Forecast, Size, Trends and Insights - IndexBoxBioWorldViva in vivo! At EHA, in vivo CAR T data continues to impressIlluminaWhat is proteomics? A simple guide to understanding measuring proteins at scale - IlluminaBrady CorporationWorld Biohazard Spill Kits - Market Analysis, Forecast, Size, Trends and Insights - IndexBoxFritsch GmbHWorld Laser Diffraction Optical Units - Market Analysis, Forecast, Size, Trends and Insights - IndexBoxTSI IncorporatedHot Wire Anemometers Market Growth Outlook to 2035: Innovation and Regulatory Tailwinds - News and Statistics - IndexBoxNovo NordiskNovo Nordisk’s CagriSema Breakthrough Expands Growth Story Beyond Diabetes and Obesity - simplywall.st
BioWorld 2026년 1월 28일

Di’ao Group Chengdu Pharmaceutical identifies GLP-1R agonists

Di’ao Group Chengdu Pharmaceutical identifies GLP-1R agonists

원문
본문을 이용할 수 없습니다. 원본 출처를 확인하세요.